Welcome to LookChem.com Sign In|Join Free
  • or
2-(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)ethanamine hydrochloride (1:1) is a complex organic compound with the molecular formula C20H24ClNO2. It is a derivative of the indole class of compounds, characterized by a benzyl group attached to the nitrogen atom, a methoxy group at the 5-position, and a methyl group at the 2-position. The hydrochloride salt form indicates that it is a protonated version of the base compound, which can affect its solubility and stability. This chemical is often used in pharmaceutical applications, particularly as an intermediate in the synthesis of various drugs, due to its potential to interact with biological targets such as receptors and enzymes. The 1:1 ratio in the name refers to the stoichiometric ratio of the compound to its hydrochloride counterion, suggesting that one molecule of the base compound is combined with one molecule of hydrochloric acid to form the salt.

525-02-0

Post Buying Request

525-02-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

525-02-0 Usage

Uses

Used in Scientific Research:
2-(1-benzyl-5-methoxy-2-methyl-1H-indol-3-yl)ethanamine hydrochloride (1:1) is used as a research chemical for studying its psychoactive properties and potential interactions with serotonin receptors. Its stability and solubility make it an ideal candidate for laboratory experiments and investigations into its effects on behavior, mood, and cognition.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2-(1-benzyl-5-methoxy-2-methyl-1H-indol-3-yl)ethanamine hydrochloride (1:1) is utilized as a starting material or intermediate in the synthesis of new drugs targeting serotonin receptors. Its potential agonistic effects on these receptors make it a promising candidate for the development of medications aimed at treating various mental health disorders and conditions related to mood and cognition.

Check Digit Verification of cas no

The CAS Registry Mumber 525-02-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,2 and 5 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 525-02:
(5*5)+(4*2)+(3*5)+(2*0)+(1*2)=50
50 % 10 = 0
So 525-02-0 is a valid CAS Registry Number.

525-02-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(1-benzyl-5-methoxy-2-methylindol-3-yl)ethanamine,hydrochloride

1.2 Other means of identification

Product number -
Other names 1-Benzyl-2,5-dimethylserotonin hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:525-02-0 SDS

525-02-0Relevant academic research and scientific papers

Structure-Activity Relationships of Novel Tryptamine-Based Inhibitors of Bacterial Transglycosylase

Sosi?, Izidor,Anderluh, Marko,Sova, Matej,Gobec, Martina,Mlinari? Ra??an, Irena,Derouaux, Adeline,Amoroso, Ana,Terrak, Mohammed,Breukink, Eefjan,Gobec, Stanislav

supporting information, p. 9712 - 9721 (2016/01/12)

Penicillin-binding proteins represent well-established, validated, and still very promising targets for the design and development of new antibacterial agents. The transglycosylase domain of penicillin-binding proteins is especially important, as it catalyzes polymerization of glycan chains, using the peptidoglycan precursor lipid II as a substrate. On the basis of the previous discovery of a noncovalent small-molecule inhibitor of transglycosylase activity, we systematically explored the structure-activity relationships of these tryptamine-based inhibitors. The main aim was to reduce the nonspecific cytotoxic properties of the initial hit compound and concurrently to retain the mode of its inhibition. A focused library of tryptamine-based compounds was synthesized, characterized, and evaluated biochemically. The results presented here show the successful reduction of the nonspecific cytotoxicity, and the retention of the inhibition of transglycosylase enzymatic activity, as well as the ability of these compounds to bind to lipid II and to have antibacterial actions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 525-02-0